MiR-526b-3p Inhibits the Resistance of Glioma Cells to Adriamycin by Targeting MAPRE1
Published 2022 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
MiR-526b-3p Inhibits the Resistance of Glioma Cells to Adriamycin by Targeting MAPRE1
Authors
Keywords
-
Journal
Journal of Oncology
Volume 2022, Issue -, Pages 1-13
Publisher
Hindawi Limited
Online
2022-02-14
DOI
10.1155/2022/2402212
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- SRSF10 inhibits biogenesis of circ-ATXN1 to regulate glioma angiogenesis via miR-526b-3p/MMP2 pathway
- (2020) Xiaobai Liu et al. JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH
- Signal transduction pathways and resistance to targeted therapies in glioma
- (2019) Arata Tomiyama et al. SEMINARS IN CANCER BIOLOGY
- Downregulation of miR-125b promotes resistance of glioma cells to TRAIL through overexpression of Tafazzin which is a mitochondrial protein
- (2019) Wenjia Ma et al. Aging-US
- miR-526b-3p serves as a prognostic factor and regulates the proliferation, invasion, and migration of glioma through targeting WEE1
- (2019) Ming Wu et al. Cancer Management and Research
- Preventive Care: How Mammography Utilization Changes as Women Age
- (2019) Cindy Yuan et al. Journal of the American College of Radiology
- miRNA 146a promotes chemotherapy resistance in lung cancer cells by targeting DNA damage inducible transcript 3 (CHOP)
- (2018) Wenfeng Tan et al. CANCER LETTERS
- MicroRNA-519d-3p inhibits proliferation and promotes apoptosis by targeting HIF-2α in cervical cancer under hypoxic conditions
- (2018) Lixia Jiang et al. ONCOLOGY RESEARCH
- Challenges in the Treatment of Glioblastoma: Multisystem Mechanisms of Therapeutic Resistance
- (2018) Evan K. Noch et al. World Neurosurgery
- MicroRNA-195 reverses the resistance to temozolomide through targeting cyclin E1 in glioma cells
- (2018) Hongqin Wang et al. ANTI-CANCER DRUGS
- MiR-181b-5p modulates chemosensitivity of glioma cells to temozolomide by targeting Bcl-2
- (2018) Xiyue Zhang et al. BIOMEDICINE & PHARMACOTHERAPY
- Combinatorial expression of microtubule-associated EB1 and ATIP3 biomarkers improves breast cancer prognosis
- (2018) Sylvie Rodrigues-Ferreira et al. BREAST CANCER RESEARCH AND TREATMENT
- miR-186 reverses cisplatin resistance and inhibits the�formation of the glioblastoma-initiating cell�phenotype by degrading Yin Yang 1 in glioblastoma
- (2018) Jian Li et al. INTERNATIONAL JOURNAL OF MOLECULAR MEDICINE
- An overview of microRNAs: Biology, functions, therapeutics, and analysis methods
- (2018) Kioomars Saliminejad et al. JOURNAL OF CELLULAR PHYSIOLOGY
- Exosomal transfer of tumor-associated macrophage-derived miR-21 confers cisplatin resistance in gastric cancer cells
- (2017) Peiming Zheng et al. JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH
- miR-19a promotes colorectal cancer proliferation and migration by targeting TIA1
- (2017) Yanqing Liu et al. Molecular Cancer
- miRNA-133a attenuates lipid accumulation via TR4-CD36 pathway in macrophages
- (2016) Xiao-Ping Peng et al. BIOCHIMIE
- The Prodrome of Extensor Pollicis Longus Tendonitis and Rupture: Rupture May Be Preventable
- (2016) Gustave K. Diep et al. ORTHOPEDICS
- Endophilin B2 promotes inner mitochondrial membrane degradation by forming heterodimers with Endophilin B1 during mitophagy
- (2016) Yi-Han Wang et al. Scientific Reports
- MAPRE1 as a Plasma Biomarker for Early-Stage Colorectal Cancer and Adenomas
- (2015) A. Taguchi et al. Cancer Prevention Research
- Enhanced tocopherol levels during early germination events in Chamaerops humilis var. humilis seeds
- (2015) Laura Siles et al. PHYTOCHEMISTRY
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExplorePublish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn More